These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37434215)

  • 1. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo.
    Riemenschneider H; Simonetti F; Sheth U; Katona E; Roth S; Hutten S; Farny D; Michaelsen M; Nuscher B; Schmidt MK; Flatley A; Schepers A; Gruijs da Silva LA; Zhou Q; Klopstock T; Liesz A; Arzberger T; Herms J; Feederle R; Gendron TF; Dormann D; Edbauer D
    Acta Neuropathol Commun; 2023 Jul; 11(1):112. PubMed ID: 37434215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP.
    Arseni D; Chen R; Murzin AG; Peak-Chew SY; Garringer HJ; Newell KL; Kametani F; Robinson AC; Vidal R; Ghetti B; Hasegawa M; Ryskeldi-Falcon B
    Nature; 2023 Aug; 620(7975):898-903. PubMed ID: 37532939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy.
    Lo Piccolo L; Umegawachi T; Yeewa R; Potikanond S; Nimlamool W; Prachayasittikul V; Gotoh Y; Yoshida H; Yamaguchi M; Jantrapirom S
    Neurotherapeutics; 2023 Sep; 20(5):1330-1346. PubMed ID: 37493896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is restored by VCP ATPase inhibition.
    Ziff OJ; Harley J; Wang Y; Neeves J; Tyzack G; Ibrahim F; Skehel M; Chakrabarti AM; Kelly G; Patani R
    Neuron; 2023 Oct; 111(19):3011-3027.e7. PubMed ID: 37480846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia.
    Antoniani F; Cimino M; Mediani L; Vinet J; Verde EM; Secco V; Yamoah A; Tripathi P; Aronica E; Cicardi ME; Trotti D; Sterneckert J; Goswami A; Carra S
    Cell Death Discov; 2023 Jul; 9(1):248. PubMed ID: 37454169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum.
    Gittings LM; Alsop EB; Antone J; Singer M; Whitsett TG; Sattler R; Van Keuren-Jensen K
    Acta Neuropathol; 2023 Sep; 146(3):433-450. PubMed ID: 37466726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MLO-down on TDP-43.
    Dykstra M; Barmada SJ
    Brain; 2023 Sep; 146(9):3565-3567. PubMed ID: 37540028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and Aggregation.
    Candelise N; Caissutti D; Zenuni H; Nesci V; Scaricamazza S; Salvatori I; Spinello Z; Mattei V; Garofalo T; Ferri A; Valle C; Misasi R
    Mol Neurobiol; 2023 Nov; 60(11):6346-6361. PubMed ID: 37450246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis.
    Acosta-Galeana I; Hernández-Martínez R; Reyes-Cruz T; Chiquete E; Aceves-Buendia JJ
    Front Mol Neurosci; 2023; 16():1193636. PubMed ID: 37475885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimmune characterization of optineurin insufficiency mouse model during ageing.
    Mohovic N; Peradinovic J; Markovinovic A; Cimbro R; Minic Z; Dominovic M; Jakovac H; Nimac J; Rogelj B; Munitic I
    Sci Rep; 2023 Jul; 13(1):11840. PubMed ID: 37481656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular functions of eukaryotic RNA helicases and their links to human diseases.
    Bohnsack KE; Yi S; Venus S; Jankowsky E; Bohnsack MT
    Nat Rev Mol Cell Biol; 2023 Oct; 24(10):749-769. PubMed ID: 37474727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LONRF2 is a protein quality control ubiquitin ligase whose deficiency causes late-onset neurological deficits.
    Li D; Johmura Y; Morimoto S; Doi M; Nakanishi K; Ozawa M; Tsunekawa Y; Inoue-Yamauchi A; Naruse H; Matsukawa T; Takeshita Y; Suzuki N; Aoki M; Nishiyama A; Zeng X; Konishi C; Suzuki N; Nishiyama A; Harris AS; Morita M; Yamaguchi K; Furukawa Y; Nakai K; Tsuji S; Yamazaki S; Yamanashi Y; Shimada S; Okada T; Okano H; Toda T; Nakanishi M
    Nat Aging; 2023 Aug; 3(8):1001-1019. PubMed ID: 37474791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of synaptic loss in human amyotrophic lateral sclerosis spinal cord: a clinicopathological study.
    Aousji O; Feldengut S; Antonucci S; Schön M; Boeckers TM; Matschke J; Mawrin C; Ludolph AC; Del Tredici K; Roselli F; Braak H
    Acta Neuropathol Commun; 2023 Jul; 11(1):120. PubMed ID: 37491361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific vulnerability of iPSC-derived motor neurons with TDP-43 gene mutation to oxidative stress.
    Onda-Ohto A; Hasegawa-Ogawa M; Matsuno H; Shiraishi T; Bono K; Hiraki H; Kanegae Y; Iguchi Y; Okano HJ
    Mol Brain; 2023 Jul; 16(1):62. PubMed ID: 37496071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis.
    Oiwa K; Watanabe S; Onodera K; Iguchi Y; Kinoshita Y; Komine O; Sobue A; Okada Y; Katsuno M; Yamanaka K
    Sci Adv; 2023 Aug; 9(31):eadf6895. PubMed ID: 37540751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome-wide RNA binding analysis of C9orf72 poly(PR) dipeptides.
    Balendra R; Ruiz de Los Mozos I; Odeh HM; Glaria I; Milioto C; Wilson KM; Ule AM; Hallegger M; Masino L; Martin S; Patani R; Shorter J; Ule J; Isaacs AM
    Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37438085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal energy metabolism, and the effects in aging and neurodegenerative diseases.
    Yang S; Park JH; Lu HC
    Mol Neurodegener; 2023 Jul; 18(1):49. PubMed ID: 37475056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy.
    Dubowsky M; Theunissen F; Carr JM; Rogers ML
    Mol Neurobiol; 2023 Nov; 60(11):6330-6345. PubMed ID: 37450244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration.
    Zhong L; Sheng X; Wang W; Li Y; Zhuo R; Wang K; Zhang L; Hu DD; Hong Y; Chen L; Rao H; Li T; Chen M; Lin Z; Zhang YW; Wang X; Yan XX; Chen X; Bu G; Chen XF
    Immunity; 2023 Aug; 56(8):1794-1808.e8. PubMed ID: 37442133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts.
    Rifai OM; O'Shaughnessy J; Dando OR; Munro AF; Sewell MDE; Abrahams S; Waldron FM; Sibley CR; Gregory JM
    Brain; 2023 Dec; 146(12):5124-5138. PubMed ID: 37450566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.